Mobic (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which limits the production of prostaglandins that cause inflammation, pain, and fever. By sparing COX‑1 activity, it aims to maintain normal gastric and platelet function while providing anti‑inflammatory benefits.

The appropriate dose of Mobic is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of meloxicam in pregnancy and lactation has not been fully established. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Mobic, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mobic (meloxicam) is a COX‑2‑selective NSAID, which may offer a lower risk of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or naproxen. However, cardiovascular and renal safety profiles are similar, and individual response can vary.

Mobic tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and keep out of reach of children.

Mobic is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce stomach upset. Patients should swallow the tablet whole and not crush or chew it.

Serious risks include gastrointestinal ulceration or bleeding, severe skin reactions such as Stevens‑Johnson syndrome, liver injury, renal impairment, and an increased risk of cardiovascular events. Patients should be advised to seek immediate medical attention if they notice signs of these conditions.

Mobic should be avoided in individuals with known hypersensitivity to meloxicam or other oxicam NSAIDs, active gastrointestinal bleeding, severe heart failure, or those who have had a recent coronary event. It is also contraindicated in patients with severe renal or hepatic impairment unless specifically directed by a physician.